Resolor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Resolor, covering 2024-09-12 to 2024-09-12. Get the full timeline:
Most recent: EMA Authorised: Resolor (prucalopride succinate) — Takeda Pharmaceuticals International AG Ireland